Neuropsychological impairment in acute HIV and the effect of immediate antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 4, 2015, Pages 393-399

  Kore, Idil ^a   Ananworanich, Jintanat ^b,c,d   Valcour, Victor ^e   Fletcher, James L K ^b   Chalermchai, Thep ^b   Paul, Robert ^f   Reynolds, Jesse ^g   Tipsuk, Somporn ^b   Ubolyam, Sasiwimol ^b,h   Rattanamanee, Somprartthana ^b   Jagodzinski, Linda ^c,d   Kim, Jerome ^b,c,d   Spudich, Serena ^a   Phanuphak, Praphan ^b   Phanuphak, Nittaya ^b   Teeratakulpisarn, Nipat ^b   Kroon, Eugene ^b   De Souza, Mark ^b   Chomchey, Nitiya ^b   Pinyakorn, Suteeraporn ^b   Trichavaroj, Rapee ⁱ   Assawadarachai, Vatcharain ⁱ   Tantibul, Nantana ⁱ   Nuntapinit, Bessara ⁱ   Akapirat, Siriwat ⁱ   Poltavee, Kultida ⁱ   Nampueng, A ⁱ   Desai, Akash ^e   Chiao, Stephanie ^e   Busovaca, Edgar ^e   Wendelken, Lauren ^e   Tovanabutra, Sodsai ^j   Robb, Merlin ^j   Michael, Nelson ^j   Napolitano, Laura ^k   Martel, Molly ^k   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MISSOURI INSTITUTE OF MENTAL HEALTH   (United States)

^g YALE UNIVERSITY   (United States)

^h THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

ⁱ ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^j US Military HIV Research Program   (United States)

^k MONOGRAM BIOSCIENCES   (United States)

more..

Author keywords

Antiretroviral therapy; HIV infection; HIV associated neurocognitive disorder; Mild cognitive impairment; Neuropsychological tests

Indexed keywords

EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; MARAVIROC; RALTEGRAVIR; TENOFOVIR; VIRUS RNA; ANTIRETROVIRUS AGENT;

ACUTE DISEASE; ADULT; ANTIVIRAL THERAPY; ARTICLE; COGNITIVE DEFECT; COLOR TRAILS 1 TEST; COLOR TRAILS 2 TEST; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EDUCATION; FEMALE; FOLLOW UP; GROOVED PEGBOARD TEST; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; TRAIL MAKING TEST; TREATMENT DURATION; VIRUS LOAD; VIRUS TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; NERVOUS SYSTEM DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR DISORDERS; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOMOTOR DISORDERS; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84945906042     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000746     Document Type: Article

References (31)

1. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087-2096.
2. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24: 1243-1250.
3. Rosca EC, Rosca O, Simu M, et al. HIV-associated neurocognitive disorders: a historical review. Neurologist. 2012;18:64-67.
4. Chan P, Brew BJ. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV/AIDS Rep. 2014;11:317-324.
5. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007; 21:1915-1921.
6. Valcour V, Chalermchai T, Sailasuta N, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206:275-282.
7. Spudich S, Gisslen M, Hagberg L, et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011;204:753-760.
8. Atkinson JH, Higgins JA, Vigil O, et al. Psychiatric context of acute/early HIV infection. The NIMH Multisite acute HIV infection Study: IV. AIDS Behav. 2009;13:1061-1067.
9. Peterson JLE, Hecht F, Price RW, et al. Neurocognitive performance during primary HIV-1 infection [Abstract]. Paper presented at: 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA.
10. Peterson JLE, Hecht FM, Pilcher C, et al. Changes in neurocognitive performance from early HIV-1 infection to initiation of antiretroviral therapy [Abstract]. Paper presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, Washington.
11. Crum-Cianflone NF, Moore DJ, Letendre S, et al. Low prevalence of neurocognitive impairment in early diagnosed and managed HIVinfected persons. Neurology. 2013;80:371-379.
12. Moore DJ, Letendre SL, Morris S, et al. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011;17:50-57.
13. Robertson K, Jiang H, Kumwenda J, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012;55: 868-876.
14. Robertson KR, Robertson WT, Ford S, et al. J Acquir Immune Defic Syndr. 2004;36:562-566.
15. Sacktor N, Nakasujja N, Skolasky R, et al. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 2006;67:311-314.
16. Tozzi V, Balestra P, Bellagamba R, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007;45:174-182.
17. Ananworanich J, Phanuphak N, de Souza M, et al. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr. 2008;49:151-155.
18. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871-1879.
19. Heaps J, Valcour V, Chalermchai T, et al. Development of normative neuropsychological performance in Thailand for the assessment of HIVassociated neurocognitive disorders. J Clin Exp Neuropsychol. 2013;35: 1-8.
20. Peluso M, Valcour V, Ananworanich J, et al. Immediate antiretroviral therapy mitigates the development of neuronal injury in acute HIV [Abstract]. Paper presented at: 21st Conference on Retroviruses and Opportunistic Infections; 2014; Boston, MA.
21. Devlin KN, Gongvatana A, Clark US, et al. Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc. 2012;18:68-78.
22. Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10:1-14.
23. Shimizu SM, Chow DC, Valcour V, et al. The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: a study of the Hawaii aging with HIV cohort. World J AIDS. 2011;1:139-145.
24. Ellis RJ, Badiee J, Vaida F, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25:1747-1751.
25. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, et al. Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses. 2008;24:1301-1307.
26. Picker LJ. Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol. 2006;18:399-405.
27. Marra CM, Zhao Y, Clifford DB, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009;23:1359-1366.
28. Robertson KR, Su Z, Margolis DM, et al. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74:1260-1266.
29. Baldewicz TT, Leserman J, Silva SG, et al. Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav. 2004;8:345-355.
30. Martin EM, Sorensen DJ, Edelstein HE, et al. Decision-making speed in HIV-1 infection: a preliminary report. AIDS. 1992;6:109-113.
31. Reger M, Welsh R, Razani J, et al. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002; 8:410-424.